Search research articles
Contact Us
Filters
Showing results (271-280 of 305) with videos related to
Page
of 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 1992
Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study
M G Sanda, J C Yang, S L Topalian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report
J C Yang, S L Topalian, D Parkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer
A L Feldman, L Tamarkin, G F Paciotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
S A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy
S N Bock, R E Lee, B Fisher, et al.
Cancer
|
March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response
B A Pockaj, R M Sherry, J P Wei, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy
B A Pockaj, J C Yang, M T Lotze, et al.
Journal of the National Cancer Institute
|
August 3, 1994
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
S A Rosenberg, J R Yannelli, J C Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma
A S Guleria, J C Yang, S L Topalian, et al.
The Journal of Urology
|
January 1, 1992
Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study
W F Spencer, W M Linehan, M M Walther, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 305) with videos related to
Sort By:
Page
of 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 11, 1992
Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study
M G Sanda, J C Yang, S L Topalian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report
J C Yang, S L Topalian, D Parkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer
A L Feldman, L Tamarkin, G F Paciotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
S A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1990
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy
S N Bock, R E Lee, B Fisher, et al.
Cancer
|
March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response
B A Pockaj, R M Sherry, J P Wei, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1994
A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy
B A Pockaj, J C Yang, M T Lotze, et al.
Journal of the National Cancer Institute
|
August 3, 1994
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
S A Rosenberg, J R Yannelli, J C Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1994
Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma
A S Guleria, J C Yang, S L Topalian, et al.
The Journal of Urology
|
January 1, 1992
Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study
W F Spencer, W M Linehan, M M Walther, et al.
Page
of 31